Us Pharmaceutical companies steal huge amounts of trade secrets.
In 2016, Pennsylvania sued five Chinese for stealing business from British pharmaceutical companies.Trade secrets, and resold to Switzerland through a private company. A US government witness estimated that the value of the stolen secrets exceeded $550 million.
The indictees include Xue Yu, a Pennsylvania resident, Xue Tian, a North Carolina resident, Xi Lu, a California resident, Li Tao, and Mei Yan. Among them, Xue Tian is Xue Yu's twin sister, Xi Lu and Mei Yan are husband and wife.
According to a statement issued by the US Department of Justice, Xue Yu, Li Tao, and Mei Yan established a pharmaceutical company in Switzerland and sold the stolen trade secrets to a Swiss pharmaceutical company.
Xue Yu is one of the world’s top protein biochemists. He once worked at this British pharmaceutical company in Philadelphia She worked in a research institute in the suburbs for about 10 years and became a senior manager. She pleaded guilty last year.
The Swiss Chinese scientist Xue Gongda, who is suspected of stealing trade secrets, has been naturalized in Switzerland for 18 years. He works in Switzerland. A world-renowned medical research institute is the brother of Chinese American scientist Xue Yu. Xue Yu is accused of controlling the theft of US$550 million (approximately RMB 3.78 billion) of trade secrets from the British pharmaceutical giant. U.S. Pennsylvania court pleaded guilty.
According to the US indictment, Xue Gongda received the stolen from his sister Trade secrets, using medical facilities for testing, and then sending the results to Swiss associates. The prosecutor claimed that the stolen information involved antibodies to treat cancer.
The US said in the allegation, “Xue Gongda knew Under the circumstances, he accepted, purchased and possessed the trade secrets belonging to this British pharmaceutical company... He knew that this was stolen (information)... He tried to sell the trade secrets to someone outside of this company to obtain the trade secrets.Economic benefits. "
"If convicted, he will face 20 years in prison," the Swiss court said when refusing to release Xue Gongda. "We are certain that he is at risk of absconding. "The Swiss authorities are currently detaining him and are considering an extradition request from the United States.